You can buy or sell ATRA and other stocks, options, and ETFs commission-free!
Atara Biotherapeutics, Inc. Common Stock, also called Atara Biotherapeutics, is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. also delivers off-the-shelf treatments to patients with high unmet medical need.
South San Francisco, California
52 Week High
52 Week Low
-$0.92 per share
-$0.86 per share